May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Evaluating Treatment Options for High-Risk Renal Cell Cancer – Alliance for Clinical Trials in Oncology
Feb 13, 2025, 17:39

Evaluating Treatment Options for High-Risk Renal Cell Cancer – Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology shared a post on X:

“New Trial Alert!

Bradley McGregor from Dana-Farber Cancer Institute leads the Alliance for Clinical Trials in Oncology A032201 (STRIKE) to compare the effect of adding tivozanib to standard therapy pembrolizumab vs pembrolizumab alone to treat patients with high-risk renal cell cancer.”

Evaluating Treatment Options for High-Risk Renal Cell Cancer - Alliance for Clinical Trials in Oncology

Read further.

More posts featuring Alliance for Clinical Trials in Oncology.